GOLDMAN SACHS GROUP INC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 125 filers reported holding ENDOLOGIX INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$175,000
-62.9%
244,337
-1.1%
0.00%
Q3 2018$472,000
-52.4%
247,108
+41.0%
0.00%
Q2 2018$992,000
-15.1%
175,265
-36.6%
0.00%
Q1 2018$1,169,000
-9.9%
276,410
+14.0%
0.00%
Q4 2017$1,297,000
-45.5%
242,511
-54.5%
0.00%
-100.0%
Q3 2017$2,379,000
-1.5%
533,437
+7.4%
0.00%0.0%
Q2 2017$2,415,000
-1.1%
496,790
+47.3%
0.00%0.0%
Q1 2017$2,442,000
+241.5%
337,295
+169.6%
0.00%
Q4 2016$715,000
-96.6%
125,118
-92.5%
0.00%
-100.0%
Q3 2016$21,341,000
-37.3%
1,667,253
-39.0%
0.01%
-45.5%
Q2 2016$34,037,000
+1.7%
2,731,726
-31.8%
0.01%0.0%
Q1 2016$33,465,000
-21.0%
4,003,066
-6.5%
0.01%
-15.4%
Q4 2015$42,387,000
-22.7%
4,281,519
-4.3%
0.01%
-31.6%
Q3 2015$54,865,000
-4.7%
4,475,171
+19.2%
0.02%
+5.6%
Q2 2015$57,589,000
-9.2%
3,754,176
+1.0%
0.02%
-10.0%
Q1 2015$63,433,000
+105.5%
3,716,033
+84.1%
0.02%
+100.0%
Q4 2014$30,862,000
+53.1%
2,018,410
+6.1%
0.01%
+66.7%
Q3 2014$20,162,000
-48.7%
1,902,066
-26.4%
0.01%
-53.8%
Q2 2014$39,306,000
+32.5%
2,584,202
+12.1%
0.01%
+30.0%
Q1 2014$29,660,000
+260.0%
2,304,593
+387.9%
0.01%
+233.3%
Q4 2013$8,238,000
+1996.2%
472,364
+1840.8%
0.00%
Q3 2013$393,000
-44.8%
24,338
-54.6%
0.00%
Q2 2013$712,000
-52.4%
53,577
-49.0%
0.00%
-100.0%
Q4 2012$1,496,000
-1.5%
105,036
-4.4%
0.00%0.0%
Q3 2012$1,519,000
-16.0%
109,901
-6.1%
0.00%0.0%
Q2 2012$1,808,000
+49.9%
117,088
+42.2%
0.00%0.0%
Q1 2012$1,206,00082,3370.00%
Other shareholders

There were no reported owners of ENDOLOGIX INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of ENDOLOGIX INC shareholders